16 articles tagged with "biotechnology"
Hemab Therapeutics stands out in the coagulation sector with a robust financial foundation and several key clinical developments on the way.
The recent failure of a rival's clinical trial has unexpectedly bolstered Alnylam Pharmaceuticals' outlook for its TTR franchise, leading to increased investor confidence.
A research team at POSTECH, led by Professor Joongoo Lee, has developed an innovative automated method that reduces the cost of assembling cell-free systems by an impressive 95%.
As CRISPR technology advances, companies are now exploring epigenome modifications, opening new avenues for treating various diseases.
Recent advancements in hydrogel fiber technology could lead to significant improvements in imaging techniques, particularly for early breast cancer detection.
A novel fluorescence screening tool has been developed to expedite the process of identifying gene-editing targets in plants, potentially boosting crop performance and resilience.
A new study delves into the evolution of ancient light-sensing proteins, aiming to uncover their biological significance and potential applications in various fields.
In a significant move to enhance its oncology pipeline, Johnson & Johnson has announced the acquisition of Firefly Bio for $1 billion, focusing on KRAS inhibitors.
A new partnership between Alnylam and Inceptive Nucleics, valued at up to $2 billion, aims to leverage AI foundation models to enhance RNA interference therapeutics over the next three years.
Researchers at the University of Hong Kong have developed an innovative RNA-based technique that may significantly impact the treatment of neurodegenerative diseases.
